Home
VIRX
VIRX News

Latest Viracta Therapeutics Inc. (VIRX) News on November 23, 2024

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

10 days ago

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

$Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma$

GlobeNewswire

16 days ago

Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma

Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

GlobeNewswire

3 months ago

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

Viracta Therapeutics Announces New Employment Inducement Grants

GlobeNewswire

6 months ago

Viracta Therapeutics Announces New Employment Inducement Grants

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

GlobeNewswire

6 months ago

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

6 months ago

Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

GlobeNewswire

7 months ago

Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

$Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma$

GlobeNewswire

7 months ago

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

GlobeNewswire

8 months ago

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial

GlobeNewswire

9 months ago

Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

10 months ago

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Business Wire

10 months ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

Akoustis Announces Pricing of Public Offering of $10.0 Million of Common Stock

GlobeNewswire

10 months ago

Akoustis Announces Pricing of Public Offering of $10.0 Million of Common Stock

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire

10 months ago

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

Idaho Strategic CEO and President to Speak at U.S. Department of Energy's Critical Minerals Workshop

ACCESSWIRE

10 months ago

Idaho Strategic CEO and President to Speak at U.S. Department of Energy's Critical Minerals Workshop

Genius Group Announces Closing of $8.25 Million Public Offering

GlobeNewswire

10 months ago

Genius Group Announces Closing of $8.25 Million Public Offering

Loop Industries Reports Third Quarter Fiscal 2024 Results and Provides Updates on Business Developments

ACCESSWIRE

10 months ago

Loop Industries Reports Third Quarter Fiscal 2024 Results and Provides Updates on Business Developments

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

ACCESSWIRE

10 months ago

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot

ACCESSWIRE

10 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot

Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why We Think First US Bancshares (NASDAQ:FUSB) Is Well Worth Watching

Simply Wall St.

10 months ago

Here's Why We Think First US Bancshares (NASDAQ:FUSB) Is Well Worth Watching

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

GlobeNewswire

10 months ago

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Zacks

10 months ago

Top Stock Picks for Week of January 8, 2024

4 Stocks in Focus That Recently Hiked Their Dividends

Zacks

a year ago

4 Stocks in Focus That Recently Hiked Their Dividends

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

GlobeNewswire

a year ago

Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024

Stronghold Digital Mining and Elbit Systems have been highlighted as Zacks Bull and Bear of the Day

Zacks

a year ago

Stronghold Digital Mining and Elbit Systems have been highlighted as Zacks Bull and Bear of the Day

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

GlobeNewswire

a year ago

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

Viracta Therapeutics Provides Clinical Update and Outlook for 2024

GlobeNewswire

a year ago

Viracta Therapeutics Provides Clinical Update and Outlook for 2024

Cenntro Regains Compliance with Nasdaq Minimum Bid Price Rule

Business Wire

a year ago

Cenntro Regains Compliance with Nasdaq Minimum Bid Price Rule

As Imperial Petroleum (NASDAQ:IMPP) soars 31% this past week, investors may now be noticing the company's one-year earnings growth

Simply Wall St.

a year ago

As Imperial Petroleum (NASDAQ:IMPP) soars 31% this past week, investors may now be noticing the company's one-year earnings growth

Cenntro Electric Group’s LS400 Approved for California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project

Business Wire

a year ago

Cenntro Electric Group’s LS400 Approved for California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project

PR Newswire

a year ago

NUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Vista Gold Corp. Announces $20 Million Royalty with Wheaton Precious Metals Corp. on Mt Todd

Business Wire

a year ago

Vista Gold Corp. Announces $20 Million Royalty with Wheaton Precious Metals Corp. on Mt Todd

CHEERS Telepathy Elevates to AI Marketing Tool for Creative Content Across the Value Chain

PR Newswire

a year ago

CHEERS Telepathy Elevates to AI Marketing Tool for Creative Content Across the Value Chain

Viracta Therapeutics Announces Orphan Drug Designation Granted by the U.S. FDA to Nana-val for the Treatment of Nasopharyngeal Carcinoma

GlobeNewswire

a year ago

Viracta Therapeutics Announces Orphan Drug Designation Granted by the U.S. FDA to Nana-val for the Treatment of Nasopharyngeal Carcinoma

TechPrecision Corp. Provides Select Unaudited FY2023 Financial Information for Votaw Precision Technologies, Inc.

ACCESSWIRE

a year ago

TechPrecision Corp. Provides Select Unaudited FY2023 Financial Information for Votaw Precision Technologies, Inc.

Read This Before Considering Epsilon Energy Ltd. (NASDAQ:EPSN) For Its Upcoming US$0.063 Dividend

Simply Wall St.

a year ago

Read This Before Considering Epsilon Energy Ltd. (NASDAQ:EPSN) For Its Upcoming US$0.063 Dividend

Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research

PR Newswire

a year ago

Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research

Hongli Group Inc. (NASDAQ:HLP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Simply Wall St.

a year ago

Hongli Group Inc. (NASDAQ:HLP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

GlobeNewswire

a year ago

Cheer Holding Awarded "Best TMT Company"

GlobeNewswire

a year ago

Cheer Holding Unveils AI-Powered Metaverse Retail, Redefining the Future of Shopping with Next-Generation Innovation

WidePoint's Subsidiary IT Authorities Awarded New Contract to Provide Managed IT Services

ACCESSWIRE

a year ago

WidePoint's Subsidiary IT Authorities Awarded New Contract to Provide Managed IT Services

Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels

GlobeNewswire

a year ago

Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels

11 Best Coffee Stocks to Invest In

Insider Monkey

a year ago

11 Best Coffee Stocks to Invest In

NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

PR Newswire

a year ago

NUTEX HEALTH ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

GlobeNewswire

a year ago

Cheer Holding Announces Share Consolidation of Ordinary Shares

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Evie, the Smart Ring for Women from Movano Health, Available for Order Today

PR Newswire

a year ago

Evie, the Smart Ring for Women from Movano Health, Available for Order Today

Smart Share Global Limited to Report Third Quarter 2023 Results on November 27, 2023

GlobeNewswire

a year ago

Smart Share Global Limited to Report Third Quarter 2023 Results on November 27, 2023

GlobeNewswire

a year ago

CHEERS Telepathy APP Officially Launched Following Regulatory Approval

Associated Press Finance

a year ago

Rockwell Medical: Q3 Earnings Snapshot

Rockwell Medical Announces Third Quarter 2023 Results

Business Wire

a year ago

Rockwell Medical Announces Third Quarter 2023 Results

Alpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Alpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call Transcript

Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2024 Earnings Call Transcript

Flux Power Holdings, Inc. (NASDAQ:FLUX) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Flux Power Holdings, Inc. (NASDAQ:FLUX) Q1 2024 Earnings Call Transcript

Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)

GlobeNewswire

a year ago

Aligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)

GoHealth to Participate in November Conferences

PR Newswire

a year ago

GoHealth to Participate in November Conferences

These Biotech Stocks Could Double Your Money, According To Analysts

Benzinga

a year ago

These Biotech Stocks Could Double Your Money, According To Analysts

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023

Business Wire

a year ago

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023

Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Viracta Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

a year ago

Viracta Therapeutics to Present at Upcoming Investor Conferences

Great Elm Group, Inc. Schedules Fiscal 2024 First Quarter Conference Call and Webcast

GlobeNewswire

a year ago

Great Elm Group, Inc. Schedules Fiscal 2024 First Quarter Conference Call and Webcast

BuzzFeed, Inc. Announces Third Quarter 2023 Financial Results

Business Wire

a year ago

BuzzFeed, Inc. Announces Third Quarter 2023 Financial Results

Share on Social Networks: